Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 2 |
2019 | 2 |
2020 | 2 |
2023 | 2 |
2024 | 2 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Minimal Residual Disease Status Predicts Outcome in Patients With Previously Untreated Follicular Lymphoma: A Prospective Analysis of the Phase III GALLIUM Study.
J Clin Oncol. 2024 Feb 10;42(5):550-561. doi: 10.1200/JCO.23.00838. Epub 2023 Dec 14.
J Clin Oncol. 2024.
PMID: 38096461
Clinical Trial.
Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
Chitadze G, Stengel A, John-Klaua C, Bruckmüller J, Trautmann H, Kotrova M, Darzentas F, Kelm M, Pal K, Darzentas N, Bastian L, Kehden B, Wessels W, Ströh AS, Oberg HH, Altrock PM, Baer C, Meggendorfer M, Gökbuget N, Baldus CD, Haferlach C, Brüggemann M.
Chitadze G, et al. Among authors: kehden b.
Blood. 2023 Mar 30;141(13):1640-1644. doi: 10.1182/blood.2022017249.
Blood. 2023.
PMID: 36450137
Free PMC article.
No abstract available.
Item in Clipboard
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.
Burmeister T, Ströh AS, Kehden B, Trautmann H, Meyer C, Marschalek R, Larghero P, Schwartz S, Steffen B, Spriewald B, Heinicke T, Jäkel N, Westermann J, Nachtkamp K, Viardot A, Topp MS, Neumann M, Baldus CD, Gökbuget N, Brüggemann M.
Burmeister T, et al. Among authors: kehden b.
Leukemia. 2024 Mar 22. doi: 10.1038/s41375-024-02209-7. Online ahead of print.
Leukemia. 2024.
PMID: 38519799
No abstract available.
Item in Clipboard
MRD response in relapsed/refractory FL after obinutuzumab plus bendamustine or bendamustine alone in the GADOLIN trial.
Pott C, Sehn LH, Belada D, Gribben J, Hoster E, Kahl B, Kehden B, Nicolas-Virelizier E, Spielewoy N, Fingerle-Rowson G, Harbron C, Mundt K, Wassner-Fritsch E, Cheson BD.
Pott C, et al. Among authors: kehden b.
Leukemia. 2020 Feb;34(2):522-532. doi: 10.1038/s41375-019-0559-9. Epub 2019 Aug 28.
Leukemia. 2020.
PMID: 31462735
Free PMC article.
Item in Clipboard
Body fat percentiles for German children and adolescents.
Plachta-Danielzik S, Gehrke MI, Kehden B, Kromeyer-Hauschild K, Grillenberger M, Willhöft C, Bosy-Westphal A, Müller MJ.
Plachta-Danielzik S, et al. Among authors: kehden b.
Obes Facts. 2012;5(1):77-90. doi: 10.1159/000336780. Epub 2012 Mar 2.
Obes Facts. 2012.
PMID: 22433620
Free article.
Item in Clipboard
Comparison of minimal residual disease levels in bone marrow and peripheral blood in adult acute lymphoblastic leukemia.
Kotrova M, Volland A, Kehden B, Trautmann H, Ritgen M, Wäsch R, Faul C, Viardot A, Schwartz S, Baldus CD, Gökbuget N, Brüggemann M.
Kotrova M, et al. Among authors: kehden b.
Leukemia. 2020 Apr;34(4):1154-1157. doi: 10.1038/s41375-019-0599-1. Epub 2019 Oct 22.
Leukemia. 2020.
PMID: 31641191
No abstract available.
Item in Clipboard
Attributable risks for childhood overweight: evidence for limited effectiveness of prevention.
Plachta-Danielzik S, Kehden B, Landsberg B, Schaffrath Rosario A, Kurth BM, Arnold C, Graf C, Hense S, Ahrens W, Müller MJ.
Plachta-Danielzik S, et al. Among authors: kehden b.
Pediatrics. 2012 Oct;130(4):e865-71. doi: 10.1542/peds.2011-3296. Epub 2012 Sep 3.
Pediatrics. 2012.
PMID: 22945402
Item in Clipboard
Cite
Cite